Back
NLS Pharmaceutics Vs. Molecular Partners AG Industry Stock Comparison
Sell
34
NLSP
NLS Pharmaceutics
Last Price:
3.48
Seasonality Move:
43.45%
Buy
58
MOLN
Molecular Partners AG
Last Price:
5.78
Seasonality Move:
43.69%
Sell
34
NLS Pharmaceutics (NLSP)
is a Sell
Is NLS Pharmaceutics a Buy, Sell or Hold?
- The current NLS Pharmaceutics [NLSP] share price is $3.66. The Score for NLSP is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- NLSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Molecular Partners AG (MOLN)
is a Buy
Is Molecular Partners AG a Buy, Sell or Hold?
- The current Molecular Partners AG [MOLN] share price is $5.65. The Score for MOLN is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- MOLN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NLSP Stock Price Chart
What is NLS Pharmaceutics's stock price today?
-
The NLS Pharmaceutics share price today is $3.66
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
MOLN Stock Price Chart
What is Molecular Partners AG's stock price today?
-
The Molecular Partners AG share price today is $5.65
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MOLN is experiencing slight selling pressure.
NLSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 44.98 | Sell |
| Chaikin Money Flow: | 15006 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.38 - 4.18) | Sell |
| Bollinger Bands (100): | (4.11 - 7.49) | Sell |
MOLN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 50.63 | Buy |
| Chaikin Money Flow: | -565 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.41 - 6.17) | Sell |
| Bollinger Bands (100): | (5.07 - 6.57) | Sell |
NLSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.36 | Buy |
| 20-day SMA: | 3.66 | Sell |
| 50-day SMA: | 4.43 | Sell |
| 200-day SMA: | 7.12 | Sell |
| 8-day EMA: | 3.5 | Buy |
| 20-day EMA: | 3.71 | Sell |
| 50-day EMA: | 4.41 | Sell |
| 200-day EMA: | 9.14 | Sell |
MOLN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.47 | Buy |
| 20-day SMA: | 5.7 | Sell |
| 50-day SMA: | 5.38 | Buy |
| 200-day SMA: | 5.2 | Buy |
| 8-day EMA: | 5.53 | Buy |
| 20-day EMA: | 5.6 | Buy |
| 50-day EMA: | 5.6 | Buy |
| 200-day EMA: | 5.44 | Buy |
NLS Pharmaceutics Earnings Growth & NLSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Molecular Partners AG Earnings Growth & MOLN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.07 per share, and an increase next year of $0.08 per share.
NLS Pharmaceutics Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Molecular Partners AG Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||